2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT)

Historical Holders from Q4 2021 to Q3 2025

Symbol
TSVT
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
52.4M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-2
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of 2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 5.38% $14.1M 2.82M The Vanguard Group 31 Mar 2025
GOLDMAN SACHS GROUP INC 0% $1.53K 308 THE GOLDMAN SACHS GROUP, INC. 30 Jun 2025

Institutional Holders of 2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 0 $0 -$508K 0
2025 Q2 96K $508K -$233M $9.92 2
2025 Q1 47.3M $234M +$26.4M $4.94 135
2024 Q4 46M $135M -$4.23M $2.94 115
2024 Q3 45M $212M -$12.1M $4.72 112
2024 Q2 47.6M $183M +$593K $3.85 112
2024 Q1 46.6M $249M -$4.59M $5.35 112
2023 Q4 48.2M $206M -$20M $4.27 113
2023 Q3 54.8M $215M -$17.3M $3.92 140
2023 Q2 49.9M $505M +$349K $10.12 145
2023 Q1 49.8M $508M +$174M $10.20 140
2022 Q4 32.8M $308M -$29M $9.37 132
2022 Q3 33.9M $494M -$11.5M $14.55 113
2022 Q2 34.6M $457M +$34.8M $13.20 115
2022 Q1 31.9M $543M +$220M $17.06 116
2021 Q4 18.7M $479M +$479M $25.63 108